Stay updated on Rebastinib with Paclitaxel in Solid Tumors Clinical Trial

Sign up to get notified when there's something new on the Rebastinib with Paclitaxel in Solid Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Rebastinib with Paclitaxel in Solid Tumors Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    Locations information has been reorganized into a single Locations section listing all participating states (Alabama, Colorado, Illinois, Kansas, Massachusetts, New York, Ohio, Oklahoma, Pennsylvania, Rhode Island, Tennessee, Texas), replacing the prior per-state location blocks.
    Difference
    1%
    Check dated 2025-12-23T17:33:33.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    No Change Detected
  4. Check
    32 days ago
    Change Detected
    Summary
    Revision: v3.3.2 added and v3.2.0 removed. No content changes to study data are involved.
    Difference
    0.0%
    Check dated 2025-11-24T20:56:09.000Z thumbnail image
  5. Check
    39 days ago
    Change Detected
    Summary
    The government funding status notice on the page has been removed.
    Difference
    0.3%
    Check dated 2025-11-17T18:15:37.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    No significant changes to core study information (eligibility criteria, outcomes, or locations); only minor formatting and layout adjustments were observed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-11-03T13:05:51.000Z thumbnail image
  7. Check
    82 days ago
    Change Detected
    Summary
    Summary of changes: updated operating-status notice and a version bump to v3.2.0, replacing the previous v3.1.0.
    Difference
    3%
    Check dated 2025-10-05T22:47:53.000Z thumbnail image
  8. Check
    89 days ago
    Change Detected
    Summary
    Update: replacing older terms with Carcinosarcoma and updating version to v3.1.0; older term references (Ovarian cancer, Mixed Tumor, Mesodermal) and v3.0.2 are removed.
    Difference
    0.2%
    Check dated 2025-09-28T19:23:47.000Z thumbnail image

Stay in the know with updates to Rebastinib with Paclitaxel in Solid Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Rebastinib with Paclitaxel in Solid Tumors Clinical Trial page.